Monday, September 14, 2026

Cancer Gone for 3 Years? This New Drug Is Making It Happen

AbbVie's Epkinly shows 96% long-term complete remission in R/R large B-cell lymphoma patients, highlighting its effectiveness as a therapy.

Revolutionizing Drug Development: Ewha Womans University Partners with Cureverse for AI-Powered Innovations

Ewha Womans University and Cureverse Inc. partner for AI-driven drug development, focusing on collaboration and expert training.

North Korean Drone Incursion: What the Latest Investigations Reveal About Military Support

North Korean drone incursions prompt investigations into involved parties, including CEO and director of a drone startup, for illegal activities.

Chang Kyu Lee

Volkswagen’s Audi Factory Plans: Will U.S. Tariff Changes Decide Their Fate?

Volkswagen's U.S. factory plans depend on tariff reductions; CEO Blume cites significant costs from past tariffs and calls for stable conditions.

North Korean Hackers Hiding in Plain Sight at U.S. Companies

North Korean IT workers are using Chinese shell companies to infiltrate Western firms, raising concerns about security and intellectual property theft.

Top News

- Our Sponsors Ad -

Follow us